Evidence-Based Medicine Guidelines
Propranolol for infantile hemangiomas
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Propranolol for Infantile Hemangiomas." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458132/all/Propranolol_for_infantile_hemangiomas.
Propranolol for infantile hemangiomas. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/458132/all/Propranolol_for_infantile_hemangiomas. Accessed January 15, 2025.
Propranolol for infantile hemangiomas. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/458132/all/Propranolol_for_infantile_hemangiomas
Propranolol for Infantile Hemangiomas [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2025 January 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458132/all/Propranolol_for_infantile_hemangiomas.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Propranolol for infantile hemangiomas
ID - 458132
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458132/all/Propranolol_for_infantile_hemangiomas
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
